-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722.O2.3 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Monitoring, Understanding and Optimizing GVHD Interventions

Symposia: Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Translational Research, Clinical Research, Genomics, Treatment Considerations, Biological therapies, Real-world evidence, Immunotherapy, Adverse Events, Registries, Computational biology, Biological Processes, Technology and Procedures, Study Population, Human, Transplantation (Allogeneic and Autologous), Machine learning, Omics technologies
Saturday, December 7, 2024: 4:00 PM-5:30 PM
Room 6CF (San Diego Convention Center)
Moderators:
John Levine, MD, MS, Mount Sinai School of Medicine and Brian C. Shaffer, MD, MS, Memorial Sloan Kettering Cancer Center
Disclosures:
Levine: Bluebird Bio: Consultancy; Editas: Consultancy; Forte Biosciences: Consultancy; Inhibrx: Consultancy; Maat Pharma: Consultancy; Mesoblast: Consultancy; Novartis: Consultancy; X4: Consultancy; Ironwood: Consultancy; Calliditas: Consultancy; Viracor: Patents & Royalties: GVHD biomarker patent. Shaffer: Hansa Biopharma: Consultancy.
4:00 PM

Shuntaro Ikegawa, MD, PhD1*, Takeru Asano, MD, PhD2*, Bohoon Shim3*, Mehdi Borji, MS4*, Haesook T. Kim, PhD3,5, Shuqiang Li, PhD1*, Kenneth J. Livak, PhD1*, Gordon J. Freeman, PhD1,6*, Xia Bu, PhD1*, Roger Belizaire, MD, PhD6,7, Jennifer Whangbo, MD, PhD6,8, Roman M. Shapiro, MD1,6, Mahasweta Gooptu, MD6,9, Rizwan Romee, MD1,6, Sarah Nikiforow, MD, PhD1,6, Vincent T. Ho, MD1,6*, Corey S. Cutler, MD, MPH1,6, Joseph H. Antin, MD1,6, Robert J. Soiffer, MD1,6, John Koreth, MD, MBBS, PhD, DPhil1,6, Jeremy M. Simon, PhD3,5*, Catherine J. Wu, MD1,6* and Jerome Ritz, MD1,6

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Japanese Red Cross Society Himeji Hospital, Himeji, Japan
3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
4Broad Institute of MIT and Harvard, Cambridge, MA
5Harvard T.H. Chan School of Public Health, Boston, MA
6Harvard Medical School, Boston, MA
7Department of Pathology, Dana-Farber Cancer Institute, Inc., Boston, MA
8Boston Children Hospital, Boston, MA
9Department of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA

4:15 PM

Nikolaos Katsivelos, MD1*, Nikolaos Spyrou, MD1, Daniela Weber2*, Ingrid Vasova, MD3*, Francis A. Ayuk, M.D.4*, Hannah Choe, MD5, William J. Hogan, MD6, Zachariah Defilipp, MD7, Muna Qayed, MD8, Aaron Etra, MD1, Karamjeet S Sandhu, MD9, Sabrina Kraus10*, Timothy S. Olson, MD, PhD11, Elizabeth O. Hexner, MD, MSTR12, Paibel Aguayo-Hiraldo, MD13, Ran Reshef, MD, MSc14, Evelyn Ullrich, MD15, Tal Schechter-Finkelstein, MD16*, Carrie L. Kitko, MD17, Chantiya Chanswangphuwana, M.D.18*, Pietro Merli, MD19*, Yu Akahoshi, MD, PhD1,20*, Janna Baez1*, Gilbert Eng1*, Rahnuma Beheshti1*, Steven Kowalyk1*, George Morales1*, Ioannis Evangelos Louloudis, MD1*, Rachel Young1*, Ernst Holler, MD, PhD2*, Ryotaro Nakamura, MD21, James L.M. Ferrara, MD, DSc1 and John Levine, MD, MS1

1Icahn School of Medicine at Mount Sinai, New York, NY
2Internal Medicine III - Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
3Department of Internal Medicine 5, Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany
4Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
5Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital, Columbus, OH
6Division of Hematology, Mayo Clinic, Rochester, MN
7Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA
8Emory University, Winship Cancer Institute, Atlanta, GA
9Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
10Division of Hematology, University Hospital of Wurzburg, Wurzburg, Germany, Würzburg, Germany
11Children's Hospital of Philadelphia, Philadelphia, PA
12Abramson Cancer Center, Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA
13Cancer and Blood Disease Institute, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA
14Division of Hematology & Oncology, Columbia University Medical Center, New York
15Experimental Immunology, Department for Children and Adolescents Medicine, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany, Frankfurt Am Main, Germany
16The Hospital for Sick Children, Toronto, ON, CAN
17Division of Pediatric Hematology/Oncology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN
18Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
19Department of Hematology-Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
20Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
21Hematology and HCT, City of Hope National Medical Center, Duarte, CA

4:30 PM

Lingting Shi1,2*, Ajna Uzuni, MPH, MA3,4*, Michael Pressler, MS2*, David W Harle, BBiomedSc3,4*, Ximi Kevin Wang, MD, MSc3,4*, Rodney Macedo, PhD3,4*, Kirubel Belay, BSc3,4*, Christian A Gordillo, BS3,4*, Shami Chakrabarti, PhD3,4*, Erik Raps3,4*, Xumin Shen2*, Joshua Fuller, BSc2*, Tamjeed Azad5*, Jessie Huang2*, Pranik Chainani6*, José McFaline-Figueroa, PhD1,2*, Elham Azizi, PhD1,2,4,5,7 and Ran Reshef, MD, MSc3,4

1Irving Institute for Cancer Dynamics, Columbia University, New York, NY
2Department of Biomedical Engineering, Columbia University, New York, NY
3Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY
4Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
5Department of Computer Science, Columbia University, New York, NY
6Department Statistics and Data Science, Yale University, New Haven, CT
7Data Science Institute, Columbia University, New York, NY

4:45 PM

Mehrdad Abedi, MD1*, Samer A. Srour, MD2, Amandeep Salhotra, MD3, Rasmus T. Hoeg, MD1*, Edmund K. Waller, MD, PhD4, Hannah Choe, MD5, Anna Pavlova, MD, PhD6, Tamara Zharkevich, MD, PhD6*, J. Scott McClellan, MD, PhD6, Nathaniel B. Fernhoff, PhD6*, Everett H. Meyer, MD, PhD7 and Robert Lowsky, MD7*

1Comprehensive Cancer Center, University of California, Davis, Sacramento, CA
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
4Emory University Winship Cancer Institute, Atlanta, GA
5Blood and Marrow Transplantation Program, James Cancer Hospital, The Ohio State University, Columbus, OH
6Orca Bio, Menlo Park, CA
7Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA

5:00 PM

Swati Naik, MBBS1, Ying Li2*, Emily Zeng3*, Subodh Selukar, PhD4*, Senthil Velan Bhoopalan, MD, PhD5*, Rebecca Epperly, MD6, Madden Renee, MD6*, Ewelina Mamcarz2*, Esther A. Obeng, MD, PhD7, Amr Qudeimat, MD6*, Akshay Sharma, MBBS8, Ali Y Suliman, MD, MSc2*, Aimee C. Talleur, MD6, Mireya Paulina Velasquez, MD6, Caitlin Zebley, MD, PhD2*, Sarah Schell9*, Polly Adams10*, Jean-Yves Metais, Ph.D.6*, Salem M. Akel, PhD11*, Stephen Gottschalk, MD6 and Brandon M Triplett, MD6*

1Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TX
2Department of Bone Marrow Transplantation and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN
3Department of Biostatistics, St Jude Children's Research Hospital, Memphis, TN
4Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN
5Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
6Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
7Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA, Memphis
8Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, TN
9St. Jude Children's Research Hospital, Memphis, TN
10St Jude Children's Research Hospital, Memphis, TN
11St. Jude Children’s Research Hospital, Memphis, TN

5:15 PM

Yu Akahoshi, MD, PhD1,2*, Yoshihiro Inamoto, MD, PhD3, Nikolaos Spyrou, MD4, Hideki Nakasone, MD, PhD2, Francis A. Ayuk, M.D.5*, Hannah Choe, MD6, Noriko Doki7, Tetsuya Eto8*, Aaron Etra, MD4, Elizabeth O. Hexner, MD, MSTR9, Nobuhiro Hiramoto, MD10*, William J. Hogan, MD11, Ernst Holler, MD, PhD12*, Keisuke Kataoka, MD, PhD13,14, Masatsugu Tanaka, MD15*, Takashi Tanaka, MD16*, Naoyuki Uchida17, Ingrid Vasova, MD18*, Fumihiko Ishimaru, MD, PhD19, Takahiro Fukuda16*, Yi-Bin Chen, MD, MS20, Junya Kanda, MD, PhD21*, Ryotaro Nakamura, MD22, Yoshiko Atsuta23,24*, James L.M. Ferrara, MD, DSc4, Yoshinobu Kanda, MD, PhD2,25*, John Levine, MD, MS4 and Takanori Teshima, MD, PhD26

1Icahn School of Medicine at Mount Sinai, Omiya, Japan
2Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
3Department of Blood and Marrow Transplantation and Cellular Therapy, Fujita Health University, Aichi, Japan
4Icahn School of Medicine at Mount Sinai, New York, NY
5Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
6Blood and Marrow Transplantation Program, James Cancer Hospital, The Ohio State University, Columbus, OH
7Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
8Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan
9Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
10Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
11Division of Hematology, Mayo Clinic, Rochester, MN
12Internal Medicine III - Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
13Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
14Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan
15Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
16Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
17Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations TORANOMON HOSPITAL, Tokyo, Japan
18Department of Internal Medicine 5, Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany
19Japanese Red Cross Blood Service Headquarters, Tokyo, Japan
20Hematopoietic Cell Transplant and Cell Therapy Program, Massachusetts General Hospital, Boston, MA
21Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
22Hematology and HCT, City of Hope National Medical Center, Duarte, CA
23Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University, Nagakute, Japan
24The Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
25Division of Hematology, Jichi Medical University, Tochigi, Japan
26Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan

*signifies non-member of ASH